Controllable. Versatile. Simple.
*
The ULTRA Embolic Platform is a portfolio of peripheral products offering moderately distal to highly proximal occlusions, ideal for hemorrhage and other peripheral applications. It is designed for ease of use, versatility, and improved control during delivery.
-
Simple preparation (ready-to-use syringe)
-
No special delivery catheter or delivery systems required
-
Controllable material delivery
-
Radiopaque material allows for real-time visualization
-
Durable occlusion, independent of patient’s hemostatic condition
-
No toxic and painful DMSO solvents
-
No risk of catheter entrapment
-
Deliverable through standard microcatheters
†
†
*
*
*
*
*
*
Limitations of Current Embolics
Embolic products available today can be difficult to use and unpredictable.
Microspheres & Particles
-
Off-Target Embolization
-
Proximal Reflux
-
Poor Visualization
-
Catheter Clogging
Coils
-
Inconsistent Embolization
-
Recanalization
-
Often require multiple coils to achieve desired occlusion (time, cost)
-
Risk of migration
Liquids
-
Special preparation & delivery technique
-
Toxicity of DMSO
-
Customization of NBCA
-
Catheter entrapment
-
Reflux, obstruction of catheter tip
ULTRA Platform Deliveries
Pre-clinical tests demonstrating versions of the ULTRA Embolic occluding 1-3 mm diameter arteries.
Mechanism of Action
ULTRA is a shear-thinning conformable embolic platform.
The platform offers different levels of proximal occlusion by adjusting the molecules in the gel.
In the Syringe
At rest in the delivery syringe, molecules maintain a solid gel state through electrostatic interactions
When Force is Applied
When a force is applied to the gel via the syringe plunger, the molecules align allowing the material to flow through the catheter
In the Vessel
After exiting the catheter, the force is removed and the material returns to a solid gel state, occluding the vessel
Limitations of Current Embolics
Embolic products available today can be difficult to use and unpredictable.
Microspheres & Particles
-
Off-Target Embolization
-
Proximal Reflux
-
Poor Visualization
-
Catheter Clogging
Coils
-
Inconsistent Embolization
-
Recanalization
-
Often require multiple coils to achieve desired occlusion (time, cost)
-
Risk of migration
Liquids
-
Special preparation & delivery technique
-
Toxicity of DMSO
-
Customization of NBCA
-
Catheter entrapment
-
Reflux, obstruction of catheter tip
* Data on file. Fluidx Medical Technology, Inc.
† Based on in vivo study. Data on file. Fluidx Medical Technology, Inc. In vivo results are not necessarily indicative of clinical results.
The ULTRA Embolic Platform is under development and does not have marketing clearance or approval in any market at this time.